An Open Letter to the Biden Administration and Congress from multiple public health/global health academic leaders in US on "Ensuring Global Health Security via Vaccine Donation" regarding humanitarian crisis in India hividgm.ucsf.edu/ensuring-globa…
"Second year of the COVID-19 pandemic showcasing the stark inequity in global health security. The most advanced economies are entering a period of containment while the rest of the world is unable to respond or recover from the pandemic with relevant medical or economic tools"
"U.S. is on track to a summer of pre-pandemic levels of normalcy while South Asia and India in particular is reporting an estimated 1–2 million cases/day and 15,000-25,000 deaths/day. The pandemic will end when it ends for all.". Even with US vaccinating 12-15 yo, 70 million
surplus doses now (which could meet demand in S. Asia for next few months). Pending delivery of 130 million doses of Pfizer, 170 million Moderna vaccine, 180 million of the 1-dose J&J vaccine and 100 million doses of the Novavax vaccine can vaccinate additional 330 million
We call on donations of these surplus vaccines to India, Nepal, Bangladesh, Pakistan and other places with raging epidemics now from the US government since the supply exceeds what is required to vaccine the US population even 12-15. Given the massive power of the vaccines to
including a government-owned patent on #COVID vaccines, given the precedent during the HIV crisis. We now appeal to Congress & Biden Administration to donate surplus vaccine &transfer technology to India & other South Asian countries during this unprecedented crisis. Thank you.
Here is the history of HIV and IP patents and @POTUS has already expressed administration's commitment to work on waiving IP patents temporarily (though EU partners reluctant) for #covid19 vax to India/S. Asia- we call for donation of surplus doses now. time.com/6046096/india-…
• • •
Missing some Tweet in this thread? You can try to
force a refresh
This JID study was the one quoted by CDC as saying risk of outdoor transmission was 10%. However, corresponding author clarifies risk much much less than that based on review of the literature. Moreover,
there have been two additional examinations of the question not included in this review which is this report from Ireland examining >232,000 infections & finding 1/1000 linked to outside. irishtimes.com/news/ireland/i…
And this scoping review from University of Canterbury concluding that outdoor transmission very rare, citing opportunity costs of not encouraging public to congregate outdoors canterbury.ac.uk/science-engine…
TRANSMISSION routes - a PROPOSAL. Have seen all the discussion on aerosol spread of a pathogen (defined as small particles that can linger in air & ventilation most important) vs droplet spread (larger particles with gobs of spit, distance important) and I propose new definition
Which is to define a pathogen (e.g. SARS-CoV-2, TB, etc.) by the best way to keep people safe, best strategies for mitigation instead. We proposed a complementary 3-way non-pharmaceutical (NPI) triangle in this @TheLancetInfDis article. thelancet.com/journals/lanin…
Masks, distancing, ventilation being most important NPI strategies but relative importance of each being defined by (traditionally) aerosol vs droplet. Why not instead of define each pathogen by relative importance of mitigation strategies? For instance, ventilation important
I see a lot of concern on Twitter today about #B.1.617 variant evading immune response. I think it is likely more transmissible and hospitalizations and deaths increase if cases increase which is happening in India and is tragic.
However, t think B.1.617 will evade immunity from the two vaccines in India - Covaxin & AZ (nor the vaccines you have in UK - Pfizer, AZ, Moderna): This study on the #Covaxin vaccine (Bharat pharm) shows strong neutralizing Ab titers against B.1.617 biorxiv.org/content/10.110…
Moreover, and this is a KEY point, if T cells decrease our severity of disease to an infection (references here- will break them all down when have more time), what is our T cell response against the spike protein with AZ vaccine- COMPLEX and in breadth. How do we know that?
7 reasons why think immunity to COVID from vaccination or infection will be long-lived (and why I continue to marvel that CEOs of companies who stand to make profit from boosters get to message that boosters needed; instead, please donate vax to India). 1. Memory B cells:
We discussed this at more length before; remember this amazing memory B cell paper that showed us that 32 people ages 91-101 who survived 1918 flu pandemic STILL had memory B cells that could produce neutralizing antibodies to that strain 9 decades later nature.com/articles/natur…
Memory B cells last long time & hang out in germinal centers (like lymph node) until they are needed again and then come out to produce neutralizing antibodies against the pathogen. Do we know COVID-19 vaccines produce memory B cells? Yes from this paper researchsquare.com/article/rs-310…
Wanted to tweet on masking as getting a lot of interest in this today (I am not a ventilation scientist; I am just an epidemiologist/ID doctor who can see from epidemiology studies how low risk outdoor transmission is). #1, Indoor masking is important when case rates high; wrote
many papers on this over the pandemic including with experts like @linseymarr. But study after study showing how low risk of outside transmission is which led to CDC recommendation of not masking outdoors when vax & many experts to not mask outside at all unless in large crowd.
Those studied summarized by multiple people in multiple threads & we summarized some in this WSJ article below which is why so many now calling on @CDC to remove mask requirements for unvaccinated children outdoors. wsj.com/articles/take-…
Good news from #HHS: we are at the LOWEST THREAT LEVEL in the US that we have ever been in the entirety of the pandemic, when looking at cases + positivity rate + inpatient + ICU together (#vaccineswork). Taking each at time: healthdata.gov/Health/COVID-1…
-Test positivity: Last 7 days test positivity rate is lowest it has been during the pandemic: 4.0% (Light Green)
-Cases: 97 cases per 100k for the Last 7 Days down -11% from previous 7 days (Orange)
-Inpatients with COVID-19: At 5% (Light Green)
-ICU for COVID: 11% (Yellow)
.
Still only 3 states outside of the Light Green or Dark Green Zone on Inpatient Beds (MI -- orange, MD, yellow, PA -- yellow). Keep following these metrics to see the pandemic recede with the increasing roll-out of vaccine & decide when public health emergency over in US